Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Your Filters

Filter by : Author

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes

Authors : Jessica A. Regan; Robert J. Mentz; Maggie Nguyen

Subjects: Cardiology; Metabolism; Medicine

Source: JCI Insight, Vol 8, Iss 17 (2023)

Read Online Read More Add to Saved list

Academic Journal

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial

Authors : Glenn M. Chertow; Ricardo Correa‐Rotter; Priya Vart

Subjects: cardiovascular medications; chronic kidney disease; dapagliflozin

Source: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 9 (2023)

Read Online Read More Add to Saved list

Academic Journal

The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

Authors : Michele Provenzano; Niels Jongs; Priya Vart

Subjects: chronic kidney disease; DAPA-CKD; dapagliflozin

Source: Kidney International Reports, Vol 7, Iss 3, Pp 436-443 (2022)

Read Online Read More Add to Saved list

Academic Journal

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Authors : Lindsay E. Clegg; Robert C. Penland; Srinivas Bachina

Subjects: SGLT2 inhibitor; GLP-1 receptor agonist; Exenatide

Source: Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)

Read Online Read More Add to Saved list

Academic Journal

Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline

Authors : Bergur V. Stefánsson; Hiddo J.L. Heerspink; David C. Wheeler

Subjects: Anemia; Chronic kidney disease; Dapagliflozin

Source: Data in Brief, Vol 37, Iss , Pp 107237- (2021)

Read Online Read More Add to Saved list

Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria

Authors : Hiddo J.L. Heerspink; Glenn M. Chertow; Niels Jongs ...

Subjects: Transplantation; Glucosides; Diabetes Mellitus, Type 2

Source: Clinical Journal of the American Society of Nephrology, 17(11), 1665-1668. AMER SOC NEPHROLOGY

Read Online Read More Add to Saved list

Efficacy of dapagliflozin by baseline diabetes medications: A prespecified analysis from the DAPA-CKD study

Authors : Jelle M. Beernink; Frederik Persson; Niels Jongs ...

Subjects: Advanced and Specialized Nursing; Endocrinology, Diabetes and Metabolism; Internal Medicine

Source: Diabetes Care, 46(3), 602-607. AMER DIABETES ASSOCDiabetes care, 46(3), 602-607. American Diabetes Association Inc.

Read Online Read More Add to Saved list

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

Authors : Michał Nowicki; Bergur V. Stefánsson; C. David Sjöström

Subjects: eGFR slope; medicine.medical_specialty; Urinary system

Source: Wheeler, D C, Jongs, N, Stefansson, B, Chertow, G M, Greene, T, Hou, F F, Langkilde, A M, McMurray, J J, Rossing, P, Nowicki, M, Wittmann, I, Correa-Rotter, R, Sjostrom,

Read Online Read More Add to Saved list

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

Authors : John J.V. McMurray; Niels Jongs; Scott D. Solomon ...

Subjects: medicine.medical_specialty; Renal function; heart failure

Source: JACC. Heart failure, 9(11), 807-820. ELSEVIER SCI LTDMcMurray, J J V, Wheeler, D C, Stefánsson, B V, Jongs, N, Postmus, D, Correa-Rotter, R, Chertow, G M, Hou, F

Read Online Read More Add to Saved list

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

Authors : Niels Jongs; Anna Maria Langkilde; John J.V. McMurray ...

Subjects: Male; medicine.medical_specialty; Urology

Source: Journal of the American Society of Nephrology, 32(8), 2352-2361. AMER SOC NEPHROLOGYChertow, G M, Vart, P, Jongs, N, Toto, R D, Gorriz, J L, Hou, F F, McMurray, J J V, Correa-Rotter, R, Rossing,

Read Online Read More Add to Saved list